1239 related articles for article (PubMed ID: 16824156)
21. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.
Skagen CL; Jou JH; Said A
Clin Transplant; 2011; 25(3):E243-9. PubMed ID: 21323735
[TBL] [Abstract][Full Text] [Related]
22. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH
Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
[TBL] [Abstract][Full Text] [Related]
23. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Kelley M; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3187-9. PubMed ID: 16213345
[TBL] [Abstract][Full Text] [Related]
24. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
Dodson SF; Bonham CA; Geller DA; Cacciarelli TV; Rakela J; Fung JJ
Transplantation; 1999 Oct; 68(7):1058-61. PubMed ID: 10532552
[TBL] [Abstract][Full Text] [Related]
25. Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report.
Lu SC; Yan LN; Li B; Ma YK; Liu C; Wen TF; Lin QY; Zhao JC; Wang XB; Li XD; Qing S; Zhao LS; Liu C; Liu J; Zhang XH
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):196-201. PubMed ID: 14599968
[TBL] [Abstract][Full Text] [Related]
26. [A study of the efficacy and safety of using hepatitis B surface antigen-positive donors for liver transplantation].
Ju WQ; He XS; Wang DP; Deng RH; Wu LW; Guo ZY; Zhu XF; Huang JF
Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):14-6. PubMed ID: 22464699
[TBL] [Abstract][Full Text] [Related]
27. Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation.
Shitrit AB; Kramer MR; Bakal I; Morali G; Ben Ari Z; Shitrit D
Ann Thorac Surg; 2006 May; 81(5):1851-2. PubMed ID: 16631684
[TBL] [Abstract][Full Text] [Related]
28. Safe use of livers from donors with positive hepatitis B core antibody.
Manzarbeitia C; Reich DJ; Ortiz JA; Rothstein KD; Araya VR; Munoz SJ
Liver Transpl; 2002 Jun; 8(6):556-61. PubMed ID: 12037788
[TBL] [Abstract][Full Text] [Related]
29. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.
Lee KW; Lee DS; Lee HH; Kim SJ; Joh JW; Seo JM; Choe YH; Lee SK
Transplant Proc; 2004 Oct; 36(8):2311-2. PubMed ID: 15561233
[TBL] [Abstract][Full Text] [Related]
30. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
Veroux M; Corona D; Ekser B; Giaquinta A; Tallarita T; De Martino C; Gentile F; Virgilio C; Gagliano M; Fiamingo P; Veroux P
Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
[TBL] [Abstract][Full Text] [Related]
31. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
Lee S; Kim JM; Choi GS; Park JB; Kwon CH; Choe YH; Joh JW; Lee SK
Liver Transpl; 2016 Feb; 22(2):247-51. PubMed ID: 26600319
[TBL] [Abstract][Full Text] [Related]
32. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.
Roque-Afonso AM; Feray C; Samuel D; Simoneau D; Roche B; Emile JF; Gigou M; Shouval D; Dussaix E
Gut; 2002 Jan; 50(1):95-9. PubMed ID: 11772974
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
Angelico M; Nardi A; Marianelli T; Caccamo L; Romagnoli R; Tisone G; Pinna AD; Avolio AW; Fagiuoli S; Burra P; Strazzabosco M; Costa AN;
J Hepatol; 2013 Apr; 58(4):715-23. PubMed ID: 23201239
[TBL] [Abstract][Full Text] [Related]
35. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
Donataccio D; Roggen F; De Reyck C; Verbaandert C; Bodeus M; Lerut J
Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375
[TBL] [Abstract][Full Text] [Related]
36. Liver transplantation with allografts from hepatitis B core antibody-positive donors: a new approach.
Fábrega E; García-Suarez C; Guerra A; Orive A; Casafont F; Crespo J; Pons-Romero F
Liver Transpl; 2003 Sep; 9(9):916-20. PubMed ID: 12942452
[TBL] [Abstract][Full Text] [Related]
37. Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation.
Chen YC; Chuang MK; Chou NK; Chi NH; Wu IH; Chen YS; Yu HY; Huang SC; Wang CH; Tsao CI; Ko WJ; Wang SS
Transplant Proc; 2012 May; 44(4):910-2. PubMed ID: 22564582
[TBL] [Abstract][Full Text] [Related]
38. Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.
Loggi E; Micco L; Ercolani G; Cucchetti A; Bihl FK; Grazi GL; Gitto S; Bontadini A; Bernardi M; Grossi P; Costa AN; Pinna AD; Brander C; Andreone P
J Hepatol; 2012 Mar; 56(3):579-85. PubMed ID: 22027583
[TBL] [Abstract][Full Text] [Related]
39. Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
Dong C; Gao W; Ma N; Sun C; Zheng WP; Wang K; Shen ZY
Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 27933716
[TBL] [Abstract][Full Text] [Related]
40. Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.
Yaşar DG; Suyanı E; Özenirler S; Sucak GT
Transplant Proc; 2013 Mar; 45(2):833-4. PubMed ID: 23498831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
